Novartis International AG
II - In-house lobbyists and trade/business/professional associations
Companies & groups
Novartis International AG, 1
(+41) 61 324 11 11
Mr Joseph Jimenez
Chief Executive Officer
Ms Karen Strandgaard
Head of Brussels Office & EU Relations
Our mission is to care and cure.
We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest their money, their time and their ideas in our company.
Clinical Trials Regulation
Data Protection Regulation
Medical Devices Regulation
In-Vitro Diagnostic Regulation
Access to innovation
EU Trade Policy
Health Systems Performance Assessment
Health Technology Assessment
Pharmaceuticals in the environment
At European level, Novartis is committed to working in partnership with the institutions of the European Union to support policies and actions that foster positive patient outcomes
100%: 2 75%: 1 50%: 3 25%: 4
Seven associates work full-time in the Brussels office and spend between 25-100% on activities falling within the scope of the register.
Three associates at head quarters spend up to 25% of their time on activities falling within the scope of the register.
All other associates involved on activities falling within the scope of the register spend less than 10% of their time on this.
|First name||Surname||Start Date||End Date|
|Maximilian Alexander||GÖTZ VON OLENHUSEN||13/01/2015||09/01/2016|
British Chamber of Commerce, Bruegel, COCIR, EAASM, EBE, EDMA, EFPIA, EGA, Eucomed, EUCOPE, EUROMCONTACT, EuropaBio, Friends of Europe, Vaccines Europe, CEFIC, ASOP EU, CSR Europe
12/2013 - 12/2014
1,750,000 € - 1,999,999 €
No funding received from the EU institutions during the last closed financial year.
All estimates for this submission have been done following the updated Transparancy Register Implementation Guidelines of January 21st, 2015, and are consistent with the guidance provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
By its registration the organisation has signed the Transparency Register Code of Conduct.
The organisation has also declared to be bound to the following other Code:
EFPIA Code: http://transparency.efpia.eu/the-efpia-code-2